Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.43 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.43 |
| ▸ | NOS2 | P35228 | 2/20 | 0.43 |
| ▸ | S1PR3 | Q99500 | 7/20 | 0.39 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.35 |
| ▸ | SLC22A12 | Q96S37 | 3/20 | 0.35 |
| ▸ | F11 | P03951 | 2/20 | 0.34 |
| ▸ | BCL2A1 | Q16548 | 1/20 | 0.34 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7599969 | 0.83 | CYP2D6 (0.46) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL7601784 | 0.82 | CYP2D6 (0.44) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL6491537 | 0.77 | SLC6A4 (0.53) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| Hydrochloric Acid SCHEMBL6490386 | 0.76 | SLC6A4 (0.53) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL7604218 | 0.76 | SLC6A4 (0.41) | CYP2D6SLC6A2SLC6A4NOS2MRGPRX4 | |
| SCHEMBL6981893 | 0.72 | NOS2 (0.52) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL7605985 | 0.70 | SLC6A4 (0.40) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL6983849 | 0.70 | CYP2D6 (0.44) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL6577181 | 0.68 | SLC6A4 (0.53) | CYP2D6SLC6A2SLC6A4NOS2S1PR3 | |
| SCHEMBL6982533 | 0.67 | CYP2D6 (0.43) | CYP2D6SLC6A2SLC6A4NOS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2003523988-A | — | — | 2003-08-12 | — | — | JP | claimed |
| EP-1263711-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | AstraZeneca AB (SE) | 2002-12-11 | — | — | EP | claimed |
| WO-2001062704-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-08-30 | — | — | WO | claimed |
| EP-1263711-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | AstraZeneca AB (SE) | 2002-12-11 | — | — | EP | disclosed |
| WO-2001062704-A1 | NOVEL USE OF PHENYLHETEROALKYLAMINE DERIVATIVES | ASTRAZENECA AB (SE) | 2001-08-30 | — | — | WO | disclosed |